If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Silvia Mosti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Medicine & Life Sciences

Ritonavir
Multidrug-Resistant Tuberculosis
Lamivudine
HIV
HIV-1
Reverse Transcriptase Inhibitors
Nucleosides
Highly Active Antiretroviral Therapy
Disease Progression
Case Management
Mutation
Virus Diseases
Italy
Drug-Related Side Effects and Adverse Reactions
Therapeutics
Tertiary Care Centers
Hepacivirus
HIV Infections
Randomized Controlled Trials
Maintenance
T-Lymphocytes
Chemical and Drug Induced Liver Injury
Antitubercular Agents
Antiviral Agents
Interleukin-7
Viremia
RNA
Pharmaceutical Preparations
HLA-DR Antigens
Atazanavir Sulfate
Pulmonary Tuberculosis
Homeostasis
Centers for Disease Control and Prevention (U.S.)
CD4 Lymphocyte Count
Treatment Failure
Bone Density
Lost to Follow-Up
Liver
Safety
Acquired Immunodeficiency Syndrome
Viruses
Kidney
Databases
Retrospective Studies
Chronic Hepatitis C
Extensively Drug-Resistant Tuberculosis
Hyperbilirubinemia
maraviroc
Hypertriglyceridemia

Agriculture & Biology

randomized clinical trials
Human immunodeficiency virus 1
tuberculosis
Italy
immune response
drugs
T-lymphocytes
interleukin-7
viremia
disease course
homeostasis

Chemical Compounds

T-cells
Pharmaceutical Preparations
Interleukin-7
HLA-DR Antigens
Labels
Chemical activation
Recovery
maraviroc